RAS mutation nomograms to predict prognosis after radiofrequency ablation of recurrent colorectal liver metastases

Author:

Wang Ji-Chen1,Jiang Bin-Bin1,Zhang Zhong-Yi1,Liu Yu-Hui1,Shao Li-Jin1,Wang Song1,Yang Wei1,Wu Wei1,Kun Yan1

Affiliation:

1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute

Abstract

Abstract Objectives: This study was conducted to develop nomograms for predicting repeat intrahepatic recurrence (rIHR) and overall survival (OS) after radiofrequency ablation (RFA) treatment in patients with recurrent colorectal liver metastases (CLMs) after hepatectomy based on RAS mutation and clinicopathologic features. Methods: A total of 160 consecutive patients with recurrent CLMs after hepatectomy who were treated with ultrasound-guided percutaneous RFA from 2012 to 2022 were retrospectively included. Potential prognostic factors associated with rIHR and OS after RFA, identified by the competing-risks model and Cox proportional hazard model, respectively, were used to construct nomograms. The performance of each nomogram was evaluated by Harrell’s C-index and calibration curve with bootstrapping. Results: The 1-, 2-, and 3-year rIHR rates after RFA were 59%, 69%, and 74%, respectively. The 1-, 3- and 5-year OS rates were 96.2%, 66.7%, and 47.0%, respectively. Four predictive factors, RAS mutation, interval from hepatectomy to intrahepatic recurrence, carcinoembryonic antigen (CEA) level at ablation, and ablation margin, were incorporated in the rIHR nomogram with a C-index of 0.694. Five predictive factors, RAS mutation, largest CLM at hepatectomy, CEA level at ablation, extrahepatic disease, and ablation margin, were incorporated intothe OS nomogram with a C-index of 0.743. The calibration curves presented good agreement between thenomograms and actual observations. Conclusions: The established nomograms can predict the individual risk of rIHR and OS after RFA for recurrent CLMs and contribute to better individualized management. Advances in knowledge: This study highlights the predictive value of RAS mutation for rIHR and OS after RFA of recurrent CLMs.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3